ARTICLE | Clinical News
AngioGenex preclinical data
January 14, 2008 8:00 AM UTC
In mouse models of breast and lung cancer, IV administration of Id1-PCAOs significantly decreased Id1 levels in the epithelium and increased hemorrhage in both types of tumors. The compounds are pepti...